ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

WHO Names Brinker As Goodwill Ambassador

May 29, 2009

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Sprycell Approved for CML

November 5, 2010

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

Funding Opportunities (8-page issue).

April 18, 2003